We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Arsanis Nominates Preclinical Candidate for Staphylococcus aureus Program

News   May 24, 2013

 
Arsanis Nominates Preclinical Candidate for Staphylococcus aureus Program
 
 
 

RELATED ARTICLES

Zika Vaccine Shows Promise For Treating Deadly Brain Cancer

News

A Zika vaccine candidate has shown promise as a treatment for the deadliest type of brain cancer.

READ MORE

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

News

NIH-supported Phase 1 trial of potential broadly protective vaccine.

READ MORE

CRISPR Screen Identifies Gene That Helps Cells Resist West Nile, Zika Viruses

News

CRISPR used to identify a gene which helps cells resist a nasty class of pathogens.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE